Intelligence · Clinical Pipeline
Sanofi-Aventis U.S Pipeline
All ClinicalTrials.gov programs at Sanofi-Aventis U.S — phase, modality, and trial IDs.
- Programs
- 51
Quick answer
Sanofi-Aventis U.S has 51 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
-
riliprubart
Sanofi-aventis Healthcare Pty Ltd
Chronic inflammatory demyelinating polyradiculoneuropathy
1 trial -
riliprubart, riliprubart
Sanofi-aventis Healthcare Pty Ltd
Transplant Rejection
1 trial -
sarilumab
Sanofi-aventis Healthcare Pty Ltd
Systemic Juvenile Idiopathic Arthritis (sJIA)
1 trial
Frequently asked questions
How many pipeline programs does Sanofi-Aventis U.S have?
51 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This hub lists all published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.
Data attribution: Data sources · All pipeline programs